Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Salt'n'Peppa who wrote (8746)	2/12/2002 2:12:02 PM
From: Greg Spendjian	Respond to of 14101

Hi all, The question of what issues were raised by HC has been discussed here. It would have been good to have some more details in the President's message. Nevertheless, two things make me somewhat hopeful that the issues raised were not serious ones about "safety and efficacy". First, if there were such serious issues, I doubt that REK would have come out blasting away at HC's delays with both barrels. The fact that she seems to be interpreting their questions as a matter of delaying the process as opposed to totally rejecting the application may be a hint of what issues were indeed raised. Second, the stock price has actually held up pretty well, considering the shock. There was no massive panic selling. Maybe the big players are in the know as to what issues were raised. Maybe I am grasping at straws. Now waiting for the FDA. If they come through with a "yes", then whether HC gives its final approval or not will hardly make a difference to the stock price ... though it will be a negative for osteoarthritis Canadians who would like to have access to a lotion like Pennsaid.